Details for Patent: 5,286,754

Summary for Patent: 5,286,754

Title:	Pharmaceutical formulations of ciprofloxacin
Abstract:	A pharmaceutical formulation comprising by weight 30 to 95% of 1cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carb oxylic acid; 4.5 to 25% of a dry binder based on cellulose; 0 to 30% of a disintegration auxiliary based on starch; 0.5 to 10% of a disintegration auxiliary based on a cellulose derivative and/or a cross-linked polyvinyl-pyrrolidone; 0 to 2% of a flow-improving agent, and 0 to 3% of a lubricant. Tablets and capsules made from granules of the formulation, about 0.8 to 2 mm in size, exhibit high bioavailability and excellent storage stability.
Inventor(s):	Streuff; Bernd (Wermelskirchen, DE), Luchtenberg; Helmut (Niederkassel, DE)
Assignee:	Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:	07/246,576
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 5,286,754

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 5,286,754

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	3601566	Jan 21, 1986

International Family Members for US Patent 5,286,754

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	63460
Canada	1296634
China	1084188
China	87100810
Germany	3601566